Immunological memory to viral infections

Annual Review of Immunology

Volumn 22, Issue , 2004, Pages 711-743

  Welsh, Raymond M ^a   Selin, Liisa K ^a   Szomolanyi Tsuda, Eva ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antibody; B cells; Cytotoxicity; T cells; Vaccine

Indexed keywords

CHICKENPOX VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; MEASLES VACCINE; MUMPS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; RECOMBINANT VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS VACCINE; YELLOW FEVER VACCINE;

ANTIBODY RESPONSE; APOPTOSIS; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL POPULATION; CELLULAR IMMUNITY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GERMINAL CENTER; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; INFECTION CONTROL; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MEMORY CELL; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REINFECTION; REVIEW; SIGNAL TRANSDUCTION; SOMATIC HYPERMUTATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; VIRUS RESISTANCE;

ANIMALS; B-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 1642431348     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.22.012703.104527     Document Type: Review

References (235)

1. Fenner F. 1996. Poxviruses. In Virology, ed. B Fields, DM Knipe, PM Howley, pp. 2673-2702. Philadelphia: Lippincott-Raven
2. Cerwenka A, Lanier LL. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:41-49
3. Biron CA, Sen G.C. 2001. Interferons and other cytokines. In Fundamental Virology, ed. DM Knipe, PM Howley, pp. 321-351. Philadelphia: Lippincott, Williams & Wilkins
4. Selin LK, Santolucito PA, Pinto AK, Szomolanyi-Tsuda E, Welsh RM. 2001. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J. Immunol. 166:6784-94
5. Szomolanyi-Tsuda E, Welsh RM. 1996. T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J. Exp. Med. 183:403-11
6. Zinkernagel RM. 2002. On differences between immunity and immunological memory. Curr. Opin. Immunol. 14:523-36
7. Welsh RM, McFarland HI. 1993. Mechanisms of viral pathogenesis. In Viruses and Bone Marrow, ed. NS Young, pp. 3-30. New York: Marcel Dekker
8. Reis e Sousa C, Sher A, Kaye P. 1999. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr. Opin. Immunol. 11:392-99
9. Matzinger P. 2002. The danger model: a renewed sense of self. Science 296:301-5
10. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, et al. 2003. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77:4588-96
11. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. 2001. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75:10730-37
12. Sallusto F, Mackay CR, Lanzavecchia A. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:593-620
13. Sprent J, Surh CD. 2002. T cell memory. Annu. Rev. Immunol. 20:551-79
14. Butcher EC, Picker LJ. 1996. Lymphocyte homing and homeostasis. Science 272:60-66
15. Selin LK, Nahill SR, Welsh RM. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179:1933-43
16. Blattman JN, Antia R, Sourdive DJ, Wang X, Kaech SM, et al. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195:657-64
17. Harris NL, Ronchese F. 1999. The role of B7 costimulation in T-cell immunity. Immunol. Cell Biol. 77:304-11
18. Grewal IS, Flavell RA. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-36
19. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:433-40
20. + T lymphocytes. Nature 421:852-56
21. Shedlock DJ, Shen H. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337-39
22. Sun JC, Bevan MJ. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339-42
23. + T cell memory. Science 297:2060-63
24. Lauvau G, Vijh S, Kong P, Homg T, Kerksiek K, et al. 2001. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294:1735-39
25. Whitton JL, Zhang J. 1995. Principles of cytotoxic T lymphocyte induction and recognition. Curr. Top. Microbiol. Immunol. 202:247-59
26. Potsch C, Vohringer D, Pircher H. 1999. Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity. Eur. J. Immunol. 29:3562-70
27. + T cells. J. Exp. Med. 189:1765-76
28. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:415-22
29. van Stipdonk MJ, Lemmens EE, Schoenberger SP. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:423-29
30. Mercado R, Vijh S, Allen SE, Kerksiek K, Pilip IM, Pamer EG. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165:6833-39
31. Welsh RM, Selin LK. 2002. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2:417-26
32. Foulds KE, Zenewicz LA, Shedlock DJ, Jiang J, Troy AE, Shen H. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168:1528-32
33. Razvi ES, Jiang Z, Woda BA, Welsh RM. 1995. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr and Bcl-2-transgenic mice. Am. J. Pathol. 147:79-91
34. + T cells. Proc. Natl. Acad. Sci. USA 98: 6313-18
35. Masopust D, Vezys V, Marzo AL, Lefrancois L. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413-17
36. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410:101-5
37. + T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2:1067-76
38. + T cells persist in the upper respiratory tract following influenza virus infection. J. Immunol. 167:3293-99
39. Lenardo M, Chan KM, Hornung F, McFarland H, Siegel R, et al. 1999. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:221-53
40. Rathmell JC, Thompson CB. 2002. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109(Suppl.):S97-107
41. Gett AV, Sallusto F, Lanzavecchia A, Geginat J. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4:355-60
42. + T cells after antigen challenge in the absence of Fas (CD95). Eur. J. Immunol. 26:2903-10
43. Lohman BL, Razvi ES, Welsh RM. 1996. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J. Virol. 70:8199-203
44. + T cell homeostasis by perform and interferon-gamma. Science 290:1354-58
45. Lohman BL, Welsh RM. 1998. Apoptotic regulation of T cells and absence of immune deficiency in virus-infected IFN-gamma receptor knock-out mice. J. Virol. 72:7815-21
46. Petschner F, Zimmerman C, Strasser A, Grillot D, Nunez G, Pircher H. 1998. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection. Eur. J. Immunol. 28:560-69
47. + memory. Nat. Med. 7:892-93
48. + T cells. J. Immunol. 164:3950-54
49. Onami TM, Harrington LE, Williams MA, Galvan M, Larsen CP, et al. 2002. Dynamic regulation of T cell immunity by CD43. J. Immunol. 168:6022-31
50. Wang XZ, Stepp SE, Brehm MA, Chen HD, Selin LK, Welsh RM. 2003. Virus-specific CD8 T cells in peripheral tissues are more resistant to apoptosis than those in lymphoid organs. Immunity 18:631-42
51. Murali-Krishna K, Altman JD, Suresh M, Sourdive D, Zajac AJ, et al. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-87
52. Selin LK, Vergilis K, Welsh RM, Nahill SR. 1996. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J. Exp. Med. 183:2489-99
53. Maryanski JL, Attuil V, Hamrouni A, Mutin M, Rossi M, et al. 2001. Individuality of Ag-selected and preimmune TCR repertoires. Immunol. Res. 23:75-84
54. Lin MY, Welsh RM. 1998. Stability and diversity of T cell receptor (TCR) repertoire usage during lymphocytic choriomeningitis virus infection of mice. J. Exp. Med. 188:1993-2005
55. Maryanski JL, Jongeneel CV, Bucher P, Casanova JL, Walker PR. 1996. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is composed of very few clones. Immunity 4:47-55
56. Blattman JN, Sourdive DJ, Murali-Krishna K, Ahmed R, Altman JD. 2000. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J. Immunol. 165:6081-90
57. + T cell response. Immunity 18:549-59
58. Kaech SM, Wherry EJ, Konieczny BT, Ahmed R. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191-99
59. Reth M, Wienands J. 1997. Initiation and J processing of signals from the B cell antigen receptor. Annu. Rev. Immunol. 15:453-79
60. Ho F, Lortan JE, MacLennan IC, Khan M. 1986. Distinct short-lived and long-lived antibody-producing cell populations. Eur. J. Immunol. 16:1297-301
61. Sze DM, Toellner KM, Garcia de Vinuesa C, Taylor DR, MacLennan IC. 2000. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192:813-21
62. O'Connor BP, Gleeson MW, Noelle RJ, Erickson LD. 2003. The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease. Immunol. Rev. 194:61-76
63. Forster R, Kremmer E, Mattis E, Kremmer E, Wolf E, et al. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-47
64. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803
65. Forster R, Schweigard G, Johann S, Emrich T, Kremmer E, et al. 1997. Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome. Blood 90:520-25
66. Liu Y, deBoutellier O, Fujii H. 1997. Mechanisms of selection and differentiation in germinal centers. Curr. Opin. Immunol. 9:256-62
67. Han S, Zheng B, Takahashi Y, Kelsoe G. 1997. Distinctive characteristics of germinal center B cells. Semin. Immunol. 9:255-60
68. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. 2000. Class switchrecombination and hypermutation require activation-induced cytidine deaminase (AID), apotential RNA editing enzyme. Cell 102:553-63
69. vanEijk M, Defrance T, Hennino A, deGroot C. 2001. Death-receptor contribution to the germinal center reaction. Trends Immunol. 22:677-82
70. Han S, Hathcock K, Zheng B, Kepler TB, Hodes R, Kelsoe G. 1995. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155:556-67
71. Li C, Iosef C, Jia CY, Han VK, Li SS. 2003. Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors. J. Biol. Chem. 278:3852-59
72. Crotty S, Kersh EN, Cannons J, Schwartzberg PL, Ahmed R. 2003. SAP is required for generating long-term humoral immunity. Nature 421:282-87
73. Henderson A, Calame K. 1998. Transcriptional regulation during B cell development. Annu. Rev. Immunol. 16:163-200
74. Lin KI, Tunyaplin C, Calame K. 2003. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol. Rev. 194:19-28
75. Bachmann MF, Odermatt B, Hengartner H, Zinkernagel RM. 1996. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 183:2259-69
76. Szomolanyi-Tsuda E, Le QP, Garcea RL, Welsh RM. 1998. T cell-independent IgG responses in vivo are elicited by live virus infection but not by immunization with viral proteins or virus-like particles. J. Virol. 72:6665-70
77. Slifka MK, Ahmed R. 1996. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol. 4:394-400
78. Freer G, Burkhart C, Ciernik I, Bachmann MF, Hengartner H, Zinkernagel RM. 1994. Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen. J. Virol. 68:3650-55
79. Hotchin J. 1962. The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. Cold Spring Harbor Symp. Quant. Biol. 27:479-99
80. Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MBA. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275-331
81. Slifka MK, Antia R, Whitmire JK, Ahmed R. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363-72
82. Roost H-P, Bachmann MF, Haag A, Kalinke U, Pliska V, et al. 1995. Early high-affinity neutralizing anti-viral IgG responses without further improvements of affinity. Proc. Natl. Acad. Sci. USA 92:1257-61
83. Franco MA, Greenberg HB. 1999. Immunity to rotavirus infection in mice. J. Infect. Dis. 179(Suppl. 3):S466-69
84. Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K. 1997. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159:95-103
85. Tomori O. 1999. Impact of yellow fever on the developing world. Adv. Virus Res. 53:5-34
86. Zinkernagel RM, LaMarre A, Ciurea A, Hunziker L, Ochsenbein AF, et al. 2001. Neutralizing antiviral antibody responses. Adv. Immunol. 79:1-53
87. Planz O, Seiler P, Hengartner H, Zinkernagel RM. 1996. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies. Nature 382:726-29
88. Collins JT, Dunnick WA. 1993. Germline transcripts of the murine immunoglobulin gamma 2a gene: structure and induction by IFN-gamma. Int. Immunol. 5:885-91
89. Courtelier JP, Van der Logt JT, Hessen FW, Warnier G, Van Snick J. 1987. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 1988:2373-78
90. Thomsen AR, Volkert M, Marker O. 1985. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice. Immunology 55:213-23
91. Szomolanyi-Tsuda E, Welsh RM. 1998. T cell-independent anti-viral antibody responses. Curr. Opin. Immunol. 10:431-35
92. Bachmann MF, Rohrer UH, Kundig TM, Burki K, Hengartner H, Zinkernagel RM. 1993. The influence of antigen organization on B cell responsiveness. Science 262:1448-51
93. + CTL response. J. Exp. Med. 183:2129-42
94. Maloy KJ, Odermatt B, Hengartner H, Zinkernagel RM. 1998. Interferon γ-producing γδ T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. Proc. Natl. Acad. Sci. USA 95:1160-65
95. Franco MA, Greenberg HB. 1997. Immunity to rotavirus in T cell deficient mice. Virology 238:169-79
96. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, et al. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:822-29
97. Palladino G, Mozdzanowska K, Washko G, Gerhard W. 1995. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 69:2075-81
98. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Che J. 2000. B-1 and B-2 cell-derived immunoglobuHn M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192:271-80
99. Clarke SH, Staudt LM, Kavaler J, Schwartz D, Gerhard WU, Weigert MG. 1990. V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin. J. Immunol. 144:2795-801
100. Harada Y, Muramatsu M, Shibata T, Honjo T, Kuroda K. 2003. Unmutated immunoglobulin M can protect mice from death by influenza virus infection. J. Exp. Med. 197:1779-85
101. Swain SL, Croft MC, Dubey C, Haynes L, Rogers P, Zhang X, Bradley LM. 1996. From naive to memory T cells. Immunol. Rev. 150:143-67
102. Harrington LE, Galvan M, Baum LG, Altman JD, Ahmed R. 2000. Differentiating between memory effector CD8 T cells by altered expression of cell surface O-glycans. J Exp. Med. 191:1241-46
103. + T cells. Curr. Opin. Immunol. 15:336-42
104. + T cells during reconstitution of lymphopenic environments. J. Immunol. 171:655-63
105. Kieper WC, Jameson SC. 1999. Homeostatic expansion phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc. Natl. Acad. Sci. USA 96:13306-11
106. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. 2000. Interleukin-7 mediates the homeostasis of naive memory CD8 T cells in vivo. Nat. Immunol. 1:426-32
107. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, Surh CD. 2001. IL-7 is critical for homeostatic proliferation survival of naive T cells. Proc. Natl. Acad. Sci. USA 98:8732-37
108. + T cells. J. Exp. Med. 195: 1515-22
109. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057-62
110. Kassiotis G, Zamoyska R, Stockinger B. 2003. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J. Exp. Med. 197:1007-16
111. Razvi ES, Welsh RM, McFarland HI. 1995. In vivo state of antiviral CTL precursors: characterization of a cycling population containing CTL precursors in immune mice. J. Immunol. 154:620-32
112. + memory T cells. J. Immunol. 154:5870-75
113. Sallusto F, Langenkamp A, Geginat J, Lanzavecchia A. 2000. Functional subsets of memory T cells identified by CCR7 expression. Curr. Top. Microbiol. Immunol. 251:167-71
114. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-12
115. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-34
116. + T cells from a memory to memory/effector phenotype. J. Immunol. 168: 5538-50
117. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:379-85
118. Roman E, Miller E, Harmsen A, Wiley J, Von Andrian UH, et al. 2002. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196:957-68
119. van der Most RG, Murali-Krishna K, Ahmed R. 2003. Prolonged presence of effector-memory C8 T cells in the central nervous system after dengue virus encephalitis. Int. Immunol. 1:119-25
120. + T cells can be distinguished by their cytokine profiles and phenotypic markers. J. Immunol. 164:208-16
121. + T cells without selection of higher affinity TCR. Nat. Immunol. 2:711-17
122. Kersh EN, Kaech SM, Onami TM, Moran M, Wherry EJ, et al. 2003. TCR signal transduction in antigen-specific memory CD8 T cells. J. Immunol. 170:5455-63
123. + T cells. J. Immunol. 166:7009-13
124. Murphy KM, Reiner SL. 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2:933-44
125. Kaech SM, Hemby S, Kersh E, Ahmed R. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111:837-51
126. + T cells. Nature 401:76-79
127. Walzer T, Marcais A, Saltel F, Bella C, Jurdic P, Marvel J. 2003. Cutting edge: immediate RANTES secretion by resting memory CD8 T cells following antigenic stimulation. J. Immunol. 170:1615-19
128. Selin LK, Welsh RM. 1997. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus (LCMV)-immune mice after clearance of virus infection. J. Immunol. 158:5366-73
129. + memory T cells in virus-infected hosts. J. Exp. Med. 183:1367-75
130. Barber DL, Wherry EJ, Ahmed R. 2003. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171:27-31
131. Demkowicz WE, Littaua RA, Wang J, Ennis FA. 1996. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol. 70:2627-31
132. Van Epps HL, Terajima M, Mustonen J, Arstila TP, Corey EA, et al. 2002. Long-lived memory T lymphocyte responses after hantavirus infection. J. Exp. Med. 196:579-88
133. Sierra B, Garcia G, Perez AB, Morier L, Rodriguez R, et al. 2002. Long-term memory cellular immune response to dengue virus after a natural primary infection. Int. J. Infect. Dis. 6:125-28
134. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648-52
135. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286:1377-81
136. Swain SL, Hu H, Huston G. 1999. Class II-independent generation of CD4 memory T cells from effectors. Science 286:1381-83
137. Ciurea A, Klenerman P, Hunziker L, Horvath E, Odermatt B, et al. 1999. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. Proc. Natl. Acad. Sci. USA 96:11964-69
138. Prlic M, Lefrancois L, Jameson SC. 2002. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J. Exp. Med. 195:F49-52
139. + cells. J. Exp. Med. 195:1523-32
140. + T cells. J. Exp. Med. 195:1533-39
141. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168:4827-31
142. Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, et al. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195:1541-48
143. + T cells is dispensable for T cell memory. Proc. Natl. Acad. Sci. USA 100:4724-29
144. Leishman AJ, Naidenko OV, Attinger A, Koning F, Lena CJ, et al. 2001. T cell responses modulated through interaction between CD8αα and the nonclassical MHC class I molecule, TL. Science 294:1936-39
145. Liu Y, Xiong Y, Naidenko OV, Liu JH, Zhang R, et al. 2003. The crystal structure of a TL/CD8αα complex at 2.1 Å resolution: implications for modulation of T cell activation and memory. Immunity 18:205-15
146. + T cell frequencies from acute infection into long term memory. J. Immunol. 161:367-74
147. + T cells during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 161:3215-18
148. Topham DJ, Doherty PC. 1998. Longitudinal analysis of the acute Sendai virus-specific CD4 T cell response and memory. J. Immunol. 161:4530-35
149. + T cells over time. J. Immunol. 170:2022-29
150. Vieira P, Rajewsky K. 1990. Persistence of memory B cells in mice deprived of T cell help. Int. Immunol. 2:487-94
151. Veiga-Fernandes H, Walter U, Bourgeois C, McLean A, Rocha B. 2000. Response of naive and memory CD8 T cells to antigen stimulation in vivo. Nat. Immunol. 1:47-53
152. Kim SK, Brehm MA, Welsh RM, Selin LK. 2002. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J. Immunol. 169:90-98
153. + T cells to the lung during influenza pneumonia. J. Immunol. 167:6983-90
154. + T cells to the lung airways during respiratory virus infections. J. Immunol. 170:1423-29
155. Robinson HL, Pertmer TM. 2000. DNA vaccines for viral infections: basic studies and applications. Adv. Virus Res. 55:1-74
156. An LL, Whitton JL. 1997. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen. J. Virol. 71:2292-302
157. Oxenius A, Martinic MM, Hengartner H, Klenerman P. 1999. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J. Virol. 73:4120-26
158. Ciupitu A-MT, Petersson M, O'Donnell CL, Williams K, Jindal S, et al. 1998. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J. Exp. Med. 187:685-91
159. + T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 166:1813-22
160. + T cells that persist in the lungs. J. Exp. Med. 193:981-86
161. + T cell response to a influenza virus. J. Immunol. 167:2753-58
162. + T cells undergoing primary and secondary responses to infection in the same host. J. Immunol. 170:4933-42
163. + T cell immunodominance in primary and secondary influenza virus infections. J. Exp. Med. 198:399-410
164. Vieira P, Rajewsky K. 1988. The half-lives of serum immunoglobulins in adult mice. Eur. J. Immunol 18:313-16
165. Manz RA, Lohning M, Cassese G, Thiel A, Radbruch A. 1998. Survival of long-lived plasma cells is independent of antigen. Int. Immunol. 10:1703-11
166. Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, et al. 2001. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194:45-56
167. Slifka MK, Ahmed R. 1996. Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay. J. Immunol. Methods 199:37-46
168. Fazekas de St. Groth S, Webster RG. 1966. Disquisitions on original antigenic sin. II. Proof in lower creatures. J. Exp. Med. 124:347-61
169. Halstead SB. 1989. Antibody, macrophages, dengue virus infection, shock and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 11:8830-39
170. Tew JG, Mandel TE. 1979. Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice. Immunology 37:69-76
171. Bernasconi NL, Traggiai E, Lanzavecchia A. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-202
172. Mims CA. 1983. Immunopathology in virus disease. Philos. Trans. R. Soc. London Ser. B 303:189-98
173. Binder D, Fehr J, Hengartner H, Zinkernagel RM. 1997. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185:517-30
174. McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, Welsh RM. 2001. Attrition of bystander CD8 T cells during virus-induced T cell and Interferon responses. J. Virol. 75:5965-76
175. Pfizenmaier K, Jung H, Starzinski-Powitz A, Rollinghoff M, Wagner H. 1977. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. J. Immunol. 119:939-44
176. Dummer W, Niethammer AG, Baccala R, Lawson BR, Wagner N, et al. 2002. T cell homeostatic proliferation elicits effective antitumor autoimmunity. J. Clin. Invest. 110:185-92
177. Oehen S, Brduscha-Riem K. 1999. Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients : a pitfall for T cell memory studies? Eur. J. Immunol. 29:608-14
178. Selin LK, Lin MY, Kraemer KA, Schneck JP, Pardoll D, et al. 1999. Attrition of T cell memory, selective loss of lymphocytic choriomeningitis virus (LCMV) epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11:133-42
179. +-T-cell memory in mice challenged with unrelated pathogens. J. Virol. 77:7756-63
180. Brehm MA, Pinto AK, Daniels KA, Schneck JP, Welsh RM, Selin LK. 2002. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3:627-34
181. Oehen S, Waldner H, Kundig TM, Hengarter H, Zinkernagel RM. 1992. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J. Exp. Med. 176:1273-81
182. Tough DL, Borrow P, Sprent J. 1996. Induction of bystander T cell proliferation by viruses and type I interferon. Science 272:1947-50
183. + T cells. Proc. Natl. Acad. Sci. USA 96:8597-602
184. + T cell proliferation in the persistent phases of a gammaherpesvirus infection. J. Virol. 75:4435-38
185. Varga SM, Selin LK, Welsh RM. 2001. Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss. J. Immunol. 166:1554-61
186. Smith DK, Dudani R, Pedras-Vasconcelos JA, Chapdelaine Y, van Faassen H,
187. Mason D. 1998. A very high level of cross-reactivity is an essential feature of the T cell repertoire. Immunol. Today 19:395-404
188. Anderson RW, Bennick JR, Yewdell JW, Maloy WL, Coligan JE. 1992. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes. Mol. Immunol. 29:1089-96
189. + cytotoxic T cells. J. Virol. 67:4086-92
190. d-restricted, influenza specific CTL clone. Mol. Immunol. 28:1-7
191. + memory T cells by viral variants. J. Exp. Med. 190:1319-28
192. + T-cell clones specific for the dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. J. Virol. 73:398-403
193. Zivny J, DeFronzo M, Jarry W, Jameson J, Cruz J, et al. 1999. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J. Immunol. 163:2754-60
194. + CTL epitopes on nucleocapsid protein. J. Virol. 73:5301-8
195. + T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein. J. Virol. 77:5464-74
196. Shimojo N, Maloy WL, Anderson RW, Biddison WE, Coligan JE. 1989. Specificity of peptide binding by the HLA-A2.1 molecule. J. Immunol. 143:2939-47
197. Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B. 2001. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75:11392-400
198. Hohn H, Kortsik C, Tully G, Nilges K, Necker A, et al. 2003. Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120. Eur. J. Immunol. 33:1613-23
199. Selin LK, Varga SM, Wong IC, Welsh RM. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188:1705-15
200. Di Giusto CA, Bernhard JD. 1986. Erythema nodosum provoked by hepatitis B vaccine. Lancet 2:1042
201. Schlesinger C, Meyer CA, Veeraraghavan S, Koss MN. 1998. Constrictive (obliterative) bronchiolitis: diagnosis, etiology, a critical review of the literature. Ann. Diagn. Pathol. 2:321-34
202. Chen HD, Fraire AE, Joris I, Welsh RM, Selin LK. 2003. Specific history of heterologous virus infections determines antiviral immunity and immunopathology in the lung. Am. J. Pathol. 163:1341-55
203. Ostler T, Pircher H, Ehl S. 2003. "Bystander" recruitment of systemic memory T cells delays the immune response to respiratory virus infection. Eur. J. Immunol. 33:1839-48
204. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. 1969. An epidemiological study of altered clinical reactivity to respiratory syncitial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-21
205. Graham BS, Bunton LA, Wright PF, Karzon DT. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88:1026-33
206. Walzl G, Tafuro S, Moss P, Openshaw PJ, Hussell T. 2000. Influenza virus lung infection protects from respiratory syncitial virus-induced immunopathology. J. Exp. Med. 192:1317-26
207. + T cells. Immunity 15:637-46
208. Yewdell JW, Bennink JR. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51-88
209. Klenerman P, Zinkemagel RM. 1998. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394:421-22
210. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, et al. 2002. High circulating levels of the dengue virus non-structural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186:1165-68
211. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawomchaikul N, et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9:921-27
212. Moss DJ, Burrows SR, Silins SL, Misko I, Khanna R. 2001. The immunology of Epstein-Barr virus infection. Philos. Trans. R. Soc. London Ser. B 356:475-88
213. Nahill SR, Welsh RM. 1993. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 177:317-27
214. Burrows SR, Khanna R, Silins SL, Moss DJ. 1999. The influence of antiviral T-cell responses on the alloreactive repertoire. Immunol. Today 20:203-7
215. Brehm MA, Markees TG, Daniels KA, Greiner DL, Rossini AA, Welsh RM. 2003. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J. Immunol. 170:4077-86
216. Gaston JSH, Waer M. 1985. Virus-specific MHC-restricted T lymphocytes may initiate allograft rejection. Immunol. Today 6:237-39
217. Adams AB, Williams MA, Jones TR, Shirasugi N, Durham MM, et al. 2003. Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest 111:1881-95
218. Welsh RM, Markees TG, Woda BA, Daniels KA, Brehm MA, et al. 2000. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J. Virol. 74:2210-18
219. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362: 758-61
220. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJD, Suresh M, et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-13
221. Fuller MJ, Zajac AJ. 2003. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170:477-86
222. Wherry EJ, Blattman JN, Murali-Krishna K, van der MR, Ahmed R. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911-27
223. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63-75
224. + T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function. J. Exp. Med. 193:595-606
225. + T cells with a defect in effector function that is reversible on extended IL-2 incubation. J. Virol. 75:3028-33
226. + T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol. 162:1780-88
227. + T cell responses. Nat. Immunol. 3:189-95
228. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106-11
229. + T cells. J. Immunol. 168:4184-91
230. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195:893-905
231. + T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18:593-603
232. Sester M, Sester U, Gartner B, Kubuschok B, Girndt M, et al. 2002. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J. Virol. 76:3748-55
233. Virgin HW, Speck SH. 1999. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr. Opin. Immunol. 11:371-79
234. Ramakrishna C, Stohlman SA, Atkinson RD, Shlomchik MJ, Bergmann CC. 2002. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J. Immunol. 168:1204-11
235. Plotkin S, Orestein W. 1999. Vaccines. Philadelphia: Saunders